Tucson, Arizona (PRWEB) May 30, 2013
When Justin Ryder, 35, was discharged from University of Arizona Medical Center in Tucson on May 20, he had a new donor heart beating in his chest and a new baby boy waiting for him at home in Las Vegas, his heart transplant made possible by 83 days of life with the SynCardia temporary Total Artificial Heart.
“The SynCardia Total Artificial Heart is a lifesaving device for people like me who have severe heart failure,” said Ryder. “It bought me that time; it gave me that peace of mind that my new artificial heart wasn’t going to stop, that it was going to keep me alive until I got that call for a heart transplant.”
Ryder, an athletic father of four and former semi-pro arena football player, has battled heart problems most of his adult life. He was diagnosed with an enlarged heart at age 18 when he tried to join the Navy. Over the years, he underwent multiple surgeries, including mechanical replacement of his mitral and aortic valves and implantation of a pacemaker and a defibrillator. Ryder did well after each of the surgeries and was able to resume playing football.
However, by 2012, Ryder’s ejection fraction -- a measurement of how much blood the heart pumps out to the body during each beat -- had dropped to just 10% compared to a normal range of 50 to 60%. That’s when doctors approached him about implanting a device to bridge him to a heart transplant.
“The doctors told me about a left ventricular assist device (LVAD) and the Total Artificial Heart, but said the LVAD surgery was more risky due to my mechanical heart valves,” said Ryder. “I went online and researched the Total Artificial Heart as much as I could. People were doing so well on it. People were hiking, riding bikes, living day-to-day on it. I had three kids at the time and my wife was pregnant with our fourth. I knew that for me, to prolong my life, the Total Artificial Heart was the best choice.”
On Dec. 3, 2012, doctors removed Ryder’s failing heart and replaced it with the SynCardia Total Artificial Heart. Within a week of the implant surgery, he was up and walking the hospital floor. His recovery went so well that just three weeks after receiving the Total Artificial Heart, Ryder was switched to the Freedom® portable driver, the world’s first wearable power supply for the Total Artificial Heart. Weighing 13.5 pounds, the Freedom portable driver gave Ryder greater mobility within the hospital and on hospital grounds while he waited for his donor heart.
“It was easy with the Freedom driver,” said Ryder. “I played basketball, I played soccer with the Freedom driver, just wearing it in the Backpack, and never had any problems. It’s a no-brainer. If you have to make the decision to receive the Total Artificial Heart, if that’s your only decision to stay alive, I don’t even know why you’d hesitate to say yes.”
After 83 days of life with the Total Artificial Heart, on Feb. 24, Ryder received the call he’d been waiting for, that a matching donor heart had become available. However, following his heart transplant, Ryder’s body began to reject the donor heart, which delayed his recovery. By May, Ryder had regained much of his strength and was ready to be discharged from the hospital to continue his recovery at home with his wife and four children.
“I’m most looking forward to being with my family, seeing my kids,” said Ryder before his discharge. "The last time I saw them was Easter and my wife and I just had a baby boy in February, so it will be nice to get home to him. Getting back to normal is what I’ve been waiting for, for a long time.”
Watch video of Justin describing what the Total Artificial Heart means to him -
Watch video of Justin sharing his experience with the Total Artificial Heart – http://www.syncardia.com/patients/justin-ryder.html
Read the article on Justin published in the Arizona Daily Star -
The Freedom portable driver is CE approved for use in Europe and undergoing an Investigational Device Exemption (IDE) clinical study in the U.S.
CAUTION – The Freedom portable driver is an investigational device, limited by United States law to investigational use.
About the SynCardia temporary Total Artificial Heart
SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart, the SynCardia Total Artificial Heart is currently approved as a bridge to transplant for people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure). There have been more than 1,100 implants of the Total Artificial Heart, accounting for more than 300 patient years of life.
Similar to a heart transplant, the SynCardia Total Artificial Heart replaces both failing heart ventricles and the four heart valves, eliminating the symptoms and source of end-stage biventricular failure. Unlike a donor heart, the Total Artificial Heart is immediately available at SynCardia Certified Centers. It is the only device that provides immediate, safe blood flow of up to 9.5 liters per minute through each ventricle. This high volume of safe blood flow helps speed the recovery of vital organs, helping make the patient a better transplant candidate.
Forbes Ranks SynCardia #69 Among “America’s Most Promising Companies”
In its February 2013 issue, Forbes selected SynCardia as one of "America's Most Promising Companies" for the second consecutive year. On the list of 100 privately held, high-growth companies with bright futures, SynCardia was selected #69, moving up eight spots from its #77 ranking last year. See the full list of SynCardia Awards & Recognition here.
Read the full story at http://www.prweb.com/releases/2013/5/prweb10782703.htm.
Copyright©2012 Vocus, Inc.
All rights reserved